Lexeo Therapeutics (LXEO) Non Operating Interest Expenses (2022 - 2026)
Lexeo Therapeutics' Non Operating Interest Expenses was $14,000 in Q2 2026, down 44.0% from $25,000 a year earlier and down 17.6% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexeo Therapeutics' Non Operating Interest Expenses was $73,000 through Jun 30, 2026, down 38.1% year-over-year; for FY2025, it was $95,000, down 30.7% from FY2024.
- Non Operating Interest Expenses shows a three-year compound annual growth rate of 1.4% (FY2022 to FY2025).
- In earlier years, Non Operating Interest Expenses was $137,000 in FY2024 (-33.2%), $205,000 in FY2023 (+125.3%) and $91,000 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to Q3 2022.
- Compared with a year earlier, Non Operating Interest Expenses has declined for 11 straight quarters, with an average decline of 34.9% over the last eight quarters.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2023 (growth of 79.3%); the worst was Q2 2026 (a decline of 44.0%).
- Per Business Quant data, LXEO's Non Operating Interest Expenses in the three quarters before Q2 2026 was $17,000 (Q1 2026), $20,000 (Q4 2025) and $22,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lexeo Therapeutics | 265.74 Mn | 265.74 Mn | - | 14,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 52,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 29,000.00 |
API Access
Lexeo Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();